Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Agrawal Amit — Bellerophon Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Agrawal Amit

Agrawal Amit

Chief Operating Officer at Bellerophon Therapeutics, Inc. · on record since Jul 13, 2015

Insider trading activity of Agrawal Amit

Transactions on record: 1; since Jul 13, 2015

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 13, 2015

Figures computed from official regulatory filings — methodology.

Companies where Agrawal Amit has traded

Bellerophon Therapeutics, Inc.1 tx · Jul 13, 2015

Track record of Agrawal Amit

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Agrawal Amit

Co-insiders of Agrawal Amit

Abrams DavidBellerophon Therapeutics, Inc.
Allegheny New Mountain Partners L PBellerophon Therapeutics, Inc.
Amin NaseemBellerophon Therapeutics, Inc.
ARCH VENTURE FUND VI LPBellerophon Therapeutics, Inc.
ARCH VENTURE PARTNERS VI LLCBellerophon Therapeutics, Inc.
ARCH VENTURE PARTNERS VI LPBellerophon Therapeutics, Inc.
BENNETT MATTHEWBellerophon Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Bruder Scott PBellerophon Therapeutics, Inc.

BYBEE CLINTONBellerophon Therapeutics, Inc.

Cloyd Mary AnnBellerophon Therapeutics, Inc.

CRANDELL KEITHBellerophon Therapeutics, Inc.

Dekker MartinBellerophon Therapeutics, Inc.

Edmonds AmyBellerophon Therapeutics, Inc.

FARES WassimBellerophon Therapeutics, Inc.

Fernandes PeterBellerophon Therapeutics, Inc.

Heyrman ReinildeBellerophon Therapeutics, Inc.

Holt Matthew S.Bellerophon Therapeutics, Inc.

Huennekens R ScottBellerophon Therapeutics, Inc.

Kim BobaeBellerophon Therapeutics, Inc.

KLINSKY STEVEN BBellerophon Therapeutics, Inc.

Koh Bong YBellerophon Therapeutics, Inc.

Korner AssafBellerophon Therapeutics, Inc.

Laccona NicholasBellerophon Therapeutics, Inc.

Linde North America, Inc.Bellerophon Therapeutics, Inc.

Luehring JensBellerophon Therapeutics, Inc.

MEGLASSON MARTINBellerophon Therapeutics, Inc.

Moura Andre V.Bellerophon Therapeutics, Inc.

Naidu ManeshBellerophon Therapeutics, Inc.

NELSEN ROBERTBellerophon Therapeutics, Inc.

New Mountain Affiliated Investors II LPBellerophon Therapeutics, Inc.

New Mountain Capital, L.L.C.Bellerophon Therapeutics, Inc.

New Mountain Investments II, LLCBellerophon Therapeutics, Inc.

New Mountain Partners II (AIV-A) L.P.Bellerophon Therapeutics, Inc.

New Mountain Partners II (AIV-B) L.P.Bellerophon Therapeutics, Inc.

New Mountain Partners II Special (AIV-A) LPBellerophon Therapeutics, Inc.

Peacock Jonathan MBellerophon Therapeutics, Inc.

Puissance Capital Fund (GP) LLCBellerophon Therapeutics, Inc.

Puissance Capital Management (GP) LLCBellerophon Therapeutics, Inc.

Puissance Capital Management LPBellerophon Therapeutics, Inc.

Puissance Cross-Border Opportunities III LLCBellerophon Therapeutics, Inc.

Puissance Life Science Opportunities Fund VIBellerophon Therapeutics, Inc.

Quinn DeborahBellerophon Therapeutics, Inc.

Schoeps MeganBellerophon Therapeutics, Inc.

Shah Nimish PBellerophon Therapeutics, Inc.

Shah Parag SureshBellerophon Therapeutics, Inc.

Tasse DanielBellerophon Therapeutics, Inc.

Tenenbaum FabianBellerophon Therapeutics, Inc.

Teufel CrispinBellerophon Therapeutics, Inc.

VEF Management IV, LLCBellerophon Therapeutics, Inc.

VENROCK ASSOCIATES IV L PBellerophon Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Bellerophon Therapeutics, Inc.	Jul 13, 2015	AwardD	100,000	0.00 USD	$0	SEC